randomized,double blind, placebo-controlled trial of the effect of treatment with 3 hypertonic salin solution on bronchiolitis

INTERVENTION: Product Name: Ipertonic saline solution Pharmaceutical Form: Nebuliser solution INN or Proposed INN: Various CAS Number: 7647‐14‐5 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 3‐ CONDITION: Nebulized 3 hypertonic saline solution to improve clinical outcomes in children with bronchiolitis ; MedDRA version: 6.1 Level: PT Classification code 10062106 PRIMARY OUTCOME: Main Objective: Primary end point(s): Secondary Objective: INCLUSION CRITERIA: Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18‐64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range